Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elif A Oral

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 26, 2017
Estimating the prevalence of generalized and partial lipodystrophy: findings and challengesElaine Chiquette, Elif A Oral, Abhimanyu Garg, et al.
Journal of Diabetes & Metabolism|September 20, 2016
Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access ProgramNevin Ajluni, Moahad Dar, John Xu, et al.
Expert Review of Endocrinology & Metabolism|May 6, 2020
Diagnostic strategies and clinical management of lipodystrophyMaria C Foss-Freitas, Baris Akinci, Yingying Luo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 23, 2016
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndromePatrick Walden, Qingmei Jiang, Elizabeth A Jackson, et al.
Minerva Chirurgica|July 28, 2017
Roux-en-Y gastric bypass versus sleeve gastrectomy: risks and benefitsMatthew D Ettleson, Corey J Lager, Andrew T Kraftson, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|July 8, 2011
The metabolic fitness program: lifestyle modification for the metabolic syndrome using the resources of cardiac rehabilitationMelvyn Rubenfire, Lynette Mollo, Sangeetha Krishnan, et al.
Diabetes Care|February 1, 2024
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial LipodystrophyMaria C Foss-Freitas, Salman Imam, Adam Neidert, et al.
Clinical Diabetes and Endocrinology|March 30, 2019
Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to MetreleptinNazanene H Esfandiari, Melvyn Rubenfire, Adam H Neidert, et al.
American Journal of Preventive Cardiology|December 11, 2025
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted <i>APOC3</i> antisense oligonucleotideArchna Bajaj, Elif A Oral, Alan Brown, et al.
Obesity Facts|November 12, 2023
A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial LipodystrophyMaria C Foss-Freitas, Özge Besci, Rasimcan Meral, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 26, 2017
Estimating the prevalence of generalized and partial lipodystrophy: findings and challengesElaine Chiquette, Elif A Oral, Abhimanyu Garg, et al.
Journal of Diabetes & Metabolism|September 20, 2016
Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access ProgramNevin Ajluni, Moahad Dar, John Xu, et al.
Expert Review of Endocrinology & Metabolism|May 6, 2020
Diagnostic strategies and clinical management of lipodystrophyMaria C Foss-Freitas, Baris Akinci, Yingying Luo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 23, 2016
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndromePatrick Walden, Qingmei Jiang, Elizabeth A Jackson, et al.
Minerva Chirurgica|July 28, 2017
Roux-en-Y gastric bypass versus sleeve gastrectomy: risks and benefitsMatthew D Ettleson, Corey J Lager, Andrew T Kraftson, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|July 8, 2011
The metabolic fitness program: lifestyle modification for the metabolic syndrome using the resources of cardiac rehabilitationMelvyn Rubenfire, Lynette Mollo, Sangeetha Krishnan, et al.
Diabetes Care|February 1, 2024
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial LipodystrophyMaria C Foss-Freitas, Salman Imam, Adam Neidert, et al.
Clinical Diabetes and Endocrinology|March 30, 2019
Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to MetreleptinNazanene H Esfandiari, Melvyn Rubenfire, Adam H Neidert, et al.
American Journal of Preventive Cardiology|December 11, 2025
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted <i>APOC3</i> antisense oligonucleotideArchna Bajaj, Elif A Oral, Alan Brown, et al.
Obesity Facts|November 12, 2023
A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial LipodystrophyMaria C Foss-Freitas, Özge Besci, Rasimcan Meral, et al.
Pageof 8